KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cineverse (CNVS) Total Non-Current Liabilities (2017 - 2025)

Cineverse (CNVS) has disclosed Total Non-Current Liabilities for 14 consecutive years, with $30.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Total Non-Current Liabilities fell 30.02% year-over-year to $30.8 million, compared with a TTM value of $30.8 million through Dec 2025, down 30.02%, and an annual FY2025 reading of $34.7 million, up 7.9% over the prior year.
  • Total Non-Current Liabilities was $30.8 million for Q4 2025 at Cineverse, up from $25.4 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $62.0 million in Q1 2022 and bottomed at $25.4 million in Q2 2025.
  • Average Total Non-Current Liabilities over 5 years is $41.4 million, with a median of $38.8 million recorded in 2023.
  • The sharpest move saw Total Non-Current Liabilities crashed 54.06% in 2021, then increased 10.58% in 2024.
  • Year by year, Total Non-Current Liabilities stood at $57.0 million in 2021, then increased by 8.74% to $62.0 million in 2022, then plummeted by 35.75% to $39.8 million in 2023, then rose by 10.58% to $44.1 million in 2024, then tumbled by 30.02% to $30.8 million in 2025.
  • Business Quant data shows Total Non-Current Liabilities for CNVS at $30.8 million in Q4 2025, $25.4 million in Q2 2025, and $34.7 million in Q1 2025.